Results 161 to 170 of about 10,277 (200)

Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy-A Narrative Review. [PDF]

J Clin Med
Kędzierska M, Bańkosz M.
europepmc   +1 more source

Cetuximab-Toxin Conjugate and NPe6 with Light Enhanced Cytotoxic Effects in Head and Neck Squamous Cell Carcinoma In Vitro. [PDF]

Biomedicines
Komatsu N, Kosai A, Kuroda M, Hamakubo T, Abe T.   +4 more
europepmc   +1 more source

An Animal Model of Alzheimer\u27s: The Use of the Neurotoxin AF64A in Combination with Glucocorticoids to Differentiate the Importance of Cholinergic Pathways in Learning and Memory [PDF]

, 1995
Dornan, Faculty Advisor, Dr. Wayne, Tinkler, Gregory P.   +1 more
core   +1 more source

Neural processing in the primary auditory cortex following cholinergic lesions of the basal forebrain in ferrets. [PDF]

Hear Res
Nodal FR, Leach ND, Keating P, Dahmen JC, Zhao D, King AJ, Bajo VM.   +6 more
europepmc   +1 more source

Taming Bacterial Toxins into an Anticancer Platform. [PDF]

Biochem Biophys Res Commun
Yang C, Chen C.
europepmc   +1 more source

Recent Advances in Management of Vitiligo.

Indian J Dermatol
Das K, Sarkar R, Sinha S.
europepmc   +1 more source

Novel perspectives on MSLN-targeted cancer therapy: from molecular mechanisms to clinical translation. [PDF]

Cancer Biol Ther
Wu Z, Fu X, Feng Y, Zeng R, Qin H, Yao K.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CLL immunotoxins

Leukemia Research, 2005
Immunotoxins composed of cell-selective ligands covalently linked to peptide toxins have been developed for the treatment of chemotherapy relapsed or refractory malignancies including chronic lymphocytic leukemia (CLL). A number of CLL immunotoxins have been clinically tested including T101-ricin A, H65-ricin A, DAB(486)IL2, DAB(389)IL2, RFB4 (dsFv ...
Arthur E, Frankel, Robert J, Kreitman
openaire   +2 more sources

Recombinant immunotoxins

Breast Cancer Research and Treatment, 1996
Pseudomonas exotoxin has been genetically modified so that it targets cancer cells. This was accomplished by deleting its cell binding domain and replacing it with Fv fragments of antibodies that react with breast, colon, and other cancers. Several recombinant immunotoxins are now in clinical trials.
I, Pastan, L H, Pai, U, Brinkmann, D, FitzGerald   +3 more
openaire   +2 more sources

Immunotoxins

Expert Opinion on Pharmacotherapy, 2000
Immunotoxins are molecules which contain a protein toxin connected to a targeting antibody. The goal of therapy is for the molecule to bind selectively to cancer cells, or to cells mediating autoimmune disease, internalise and then for the toxin to kill the cell.
openaire   +2 more sources